Global Antibody Market is undergoing a period of accelerated scientific innovation and expanding therapeutic applications. Valued at USD 9.20 billion in 2024, the market is projected to climb to USD 13.47 billion by 2031, supported by a solid CAGR of 5.7%. Driven by breakthroughs in monoclonal antibody engineering, rising oncology demand, and advanced biologics manufacturing, the mark... https://www.24lifesciences.com/antibody-market-8059